LONDON - Initial results from a large study in the U.K. found that an antibody drug reduced death in hospitalized COVID-19 patients who faced the highest risk from the virus. The study was led by the ...

Coastal Pediatric Associates (CPA) has opened the Antibody Infusion Clinic for high risk, medically complex children and young adults ages 12 and older who test positive for COVID-19, but do not meet ...

Important adverse events included infusion-related and hypersensitivity reactions in 25 of 306 immunocompromised participants (8.2%) who received pemivibart and anaphylaxis in 4 of 623 participants (0 ...

The FDA issued an emergency use authorization (EUA) for pemivibart (Pemgarda) as COVID-19 pre-exposure prophylaxis in immunocompromised individuals who are unlikely to mount a sufficient immune ...

New protection against COVID-19 is now available for a group of people who need it the most – those who are moderately or severely immunocompromised. The U.S. Food and Drug Administration has ...

Sept 16 (Reuters) - Eli Lilly and Co (LLY.N), opens new tab on Wednesday said a single infusion of its experimental antibody treatment reduced the need for hospitalization and emergency room visits ...

The dominance of the Delta strain of COVID-19 combined with Alabama’s low vaccination rate has led experts to turn to monoclonal antibody infusion, a treatment in which infected individuals are ...

HUNTSVILLE, Ala. (WAFF) - There’s a new way for the most vulnerable people to fight against COVID-19, and it’s not the latest vaccine. Dr. Landers with the Alabama Department of Public Health said the ...

PHILADELPHIA (WPVI) -- It's the only authorized treatment that can help keep people with COVID-19 out of the hospital, but hundreds-of-thousands of doses aren't being used. The effectiveness of ...

Pemgarda, available in the coming weeks, is intended for immunocompromised people who are unlikely to mount an adequate response after vaccination. By Dani Blum The Food and Drug Administration has ...

The race is on for new treatments that stand up to omicron's explosive spread. With omicron's explosive spread threatening to outpace current COVID-19 treatments, the race is on to find new options ...

Data supporting antibodies is limited compared to that for authorized vaccines. Despite more than 187 million Americans being fully vaccinated against COVID-19 and data and attestations from ...